Withings Introduces Body Scan 2 at CES 2026

Withings has returned to CES 2026 to showcase its latest smart scale, the Body Scan 2, priced at $599.95. This new model emphasizes cardiovascular and metabolic health.

Enhanced Design and Accuracy

The Body Scan 2 features eight electrodes on the scale and an additional four in a retractable handle, enhancing its data-gathering capabilities beyond typical smart scales. This inclusion allows it to gather upper-body data, making it more precise than standard models that only measure lower-body metrics.

Expanded Biomarker Tracking

One significant advancement in the Body Scan 2 is its ability to track a greater array of biomarkers. In addition to traditional metrics like weight and heart rate, the scale introduces a 90-second “longevity assessment” that evaluates over 60 biomarkers across several categories, including heart function, hypertension risk, artery health, and metabolic efficiency.

User-Friendly Health Overview

Understanding the complexity of managing over 60 health metrics can be daunting, so the Body Scan 2 also provides a simplified Health Trajectory score. This score visualizes a user’s healthspan, giving a clearer perspective on their long-term health.

A Noninvasive Approach to Metabolic Health

Unlike some competitors, Withings employs noninvasive methods to assess metabolic health. The device uses bioimpedance spectroscopy (BIS) and even analyzes foot sweat to deliver comprehensive health insights without the need for blood tests. This facilitates more frequent monitoring of metabolic indicators.

Addressing Emotional Impacts and Regulatory Hurdles

Withings is aware of the potential emotional limitations associated with weight scales and has introduced an “Eyes-Closed Mode.” This feature displays measurements with emojis instead of numbers, recorded in the app for privacy. The scale’s features, such as hypertension risk notifications, will require FDA clearance, and the company is pursuing innovative certification routes for quicker market access.

Conclusion and Availability

With its commitment to user privacy and regulatory standards, the Body Scan 2 aims to revolutionize how scales are perceived, evolving them into “longevity stations.” The launch is anticipated in Q2 2026, promising a blend of advanced health monitoring and user-friendly design.